Targeting Epstein-Barr Virus-Associated Lymphomas

Targeting Epstein-Barr Virus–Associated Lymphomas

The role of Epstein-Barr virus in Hodgkin lymphoma pathophysiology

VJHemOnc – Video Journal of Hematology & HemOnc

EBV-lymphoma treatments on the horizon

VJHemOnc – Video Journal of Hematology & HemOnc

Game Changer: New Research Connects Epstein-Barr Virus to MS

Aaron Boster MD

Nanatinostat and valganciclovir for EBV-associated lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

‘Off-the-shelf’ EBV-specific CAR-T cells for Hodgkin lymphoma

VJHemOnc – Video Journal of Hematology & HemOnc

Vaccine breakthrough for EBV-associated cancers and MS

QIMR Berghofer Medical Research Institute

Epstein Barr Virus (EBV) and Cancer

Epstein Barr Virus and Infectious Mononucleosis (pathophysiology, investigations and treatment)

Armando Hasudungan

Epstein-Barr virus associated diffuse large B-cell lymphoma of the genital tract and skin in a woman

Alexandros G. Sfakianakis

Dr. Bollard on the Treatment of EBV-Positive Lymphoma

Oral nanatinostat and valganciclovir for EBV-associated lymphomas

VJHemOnc – Video Journal of Hematology & HemOnc

Hear from the Experts: Epstein-Barr Virus Associated with Development of MS Webinar

Nourse JP (2012): Latent viral infections, mechanism of latency, pathogenesis and oncogensis

Diseases associated with the Epstein-Barr Virus

Oxford Academic (Oxford University Press)

Atara Biotherapeutics

Alliance for Regenerative Medicine

Burkitt Lymphoma Epstein–Barr Virus (EBV) Staging Non-Hodgkin lymphoma (NHL) Type African USMLE 3mn

Medicine in 3 minutes

Cellular therapy and drug access for viral lymphomas

VJHemOnc – Video Journal of Hematology & HemOnc

Epstein-Barr virus associated post-transplant lymphoproliferative disorder (EBV+ PTLD)

Dr Eve Crane - EBV-related lymphoproliferative disorders